Monique Champagne, B.Pharm., M.Sc. – President and Chief Executive Officer
Monique Champagne has over 30 years of experience in clinical research, drug development and regulatory affairs, acquired in the pharmaceutical and biotechnology industries. A creative manager, she has extensive experience and expertise in the first phases of oncology drug development, in clinical development in various therapeutic areas, clinical operations management, regulatory affairs, integration and improvement of operational processes, as well as in managing international projects and professional relations with business partners.
Prior to joining ILKOS THERAPEUTIC INC., Ms Champagne was Vice-President, Clinical Research and Regulatory Affairs, at Telesta Therapeutics. Before that, she held management positions at, among others, Xanthus Life Sciences, Supratek Pharma, PricewaterhouseCoopers, Quintiles (IQVIA) and Wyeth-Ayerst (Pfizer).
Monique Champagne holds a bachelor’s degree in pharmacy (B.Pharm.), a master’s degree in pharmaceutical sciences (M.Sc.) and a pharmacist licence in Quebec.
BOARD OF DIRECTORS
Michel A. Drouin, MD, FRCPC – Chief Medical Officer
Dr Michel A. Drouin is a board-certified physician (internal medicine and clinical immunology/allergy) with nearly 40 years of experience in clinical research and drug development, both as an investigator (67 trials) and as an executive physician within the pharmaceutical and biotechnology industries. He has extensive direct experience in the conduct and management of clinical trials ranging from first-in-man phase 1 studies in oncology to phase 2 and 3 international studies in various therapeutic areas. As a responsible physician, he has always prioritized the safety of clinical trial participants and the rigorous collection and analysis of study data.
Prior to joining ILKOS THERAPEUTIC INC., Dr Drouin held leadership positions at MethylGene, Bioniche Life Sciences, Xanthus Life Sciences and Wyeth Research (Pfizer).
Roxane Aubray, R.N. – Director of Clinical Operations
Roxane Aubray is a registered nurse with over 25 years of experience in the conduct of Phase 1 to 4 clinical trials. With her substantial background in nursing, pharmaceutical and biotechnology industries, she brings extensive operational experience. She has extended knowledge of Canadian, American, and European regulations and ICH/GCP guidelines and has demonstrated proven leadership and managerial skills leading international groups.
Prior to joining ILKOS THERAPEUTIC INC., Ms Aubray was Director of Clinical Operations at NEOMED Institute and previously, at Aptalis Pharma (formerly Axcan Pharma). Before that, she held management and in field positions at Wyeth-Ayerst (Pfizer). She started her career as an emergency room nurse and clinical research study coordinator.
Micheline Beauvais, CPA, MBA – Director of Finance
From the banking industry to Chief Financial Officer (CFO) of Locus Dialogue Inc., Micheline Beauvais has been working as part time CFO since 2002 for over 20 small venture-backed technology startup companies, ranging from biotechs to Internet ventures. Well-versed in all aspects of financial management, she brings extensive experience in accounting, auditing, control and taxation, as well as expertise in the set-up and management of financial and IT systems, establishment of corporate policies and processes, ensuring the respect of financial laws and guidelines.
A certified general accountant, Ms Beauvais successfully completed an executive MBA at Concordia University in Montreal.